Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure

Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, as its evidence is lacking in the era of repe...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Chen, Runzhen, Liu, Chen, Zhou, Peng, Li, Jiannan, Zhou, Jinying, Wang, Ying, Zhao, Xiaoxiao, Chen, Yi, Yan, Shaodi, Song, Li, Zhao, Hanjun, Yan, Hongbing
التنسيق: Online مقال نص
اللغة:English
منشور في: Frontiers Media S.A. 2022
الموضوعات:
Pharmacology
الوصول للمادة أونلاين:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

الانترنت

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

مواد مشابهة